NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
17/04/2026 09:00
NASDAQ TRADE HALT KLRA.O REASON NOT AVAILABLE AT 04:00 AM
Recent news on Kailera Therapeutics
See all newsChina biotech's ingenuity extends to dealmaking
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
China biotech's ingenuity extends to dealmaking
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Kailera Therapeutics Announces Completion Of Enrollment In Kainetic Global Phase 3 Clinical Program Of Glp-1/Gip Receptor Dual Agonist Ribupatide Injection